R.H. Dinel Investment Counsel’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,550
Closed -$984K 53
2022
Q1
$984K Hold
16,550
0.76% 30
2021
Q4
$1.2M Hold
16,550
0.83% 28
2021
Q3
$1.16M Sell
16,550
-1,800
-10% -$126K 0.87% 28
2021
Q2
$1.26M Hold
18,350
0.9% 28
2021
Q1
$1.19M Hold
18,350
0.91% 28
2020
Q4
$1.07M Hold
18,350
0.86% 26
2020
Q3
$1.28M Hold
18,350
1.22% 25
2020
Q2
$1.41M Buy
18,350
+7,125
+63% +$546K 1.37% 23
2020
Q1
$839K Hold
11,225
0.99% 25
2019
Q4
$729K Hold
11,225
0.64% 31
2019
Q3
$711K Hold
11,225
0.66% 32
2019
Q2
$758K Hold
11,225
0.7% 31
2019
Q1
$730K Hold
11,225
0.72% 30
2018
Q4
$702K Buy
+11,225
New +$785K 0.79% 30
2016
Q3
$1.28M Hold
16,175
1.43% 25
2016
Q2
$1.35M Sell
16,175
-600
-4% -$53.2K 1.58% 24
2016
Q1
$1.54M Sell
16,775
-375
-2% -$33.8K 1.81% 23
2015
Q4
$1.74M Sell
17,150
-12,000
-41% -$1.25M 1.96% 21
2015
Q3
$2.86M Hold
29,150
2.99% 10
2015
Q2
$3.41M Hold
29,150
3.2% 10
2015
Q1
$2.86M Hold
29,150
2.69% 14
2014
Q4
$2.75M Hold
29,150
2.45% 14
2014
Q3
$3.1M Hold
29,150
2.81% 11
2014
Q2
$2.42M Buy
+29,150
New +$2.27M 2.2% 16

Other funds holding GILD

R.H. Dinel Investment Counsel's GILD Position: Q2 2022 in Review

R.H. Dinel Investment Counsel sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 16,550 shares — an estimated $984K sold.

R.H. Dinel Investment Counsel first reported a position in GILD in Q2 2014 and held it in 24 quarters. The position peaked at $3.41M in Q2 2015. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • R.H. Dinel Investment Counsel reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • R.H. Dinel Investment Counsel sold 16,550 Gilead Sciences shares in Q2 2022, an estimated $984K.
  • R.H. Dinel Investment Counsel first reported a position in Gilead Sciences in Q2 2014 and held it in 24 quarters.
  • R.H. Dinel Investment Counsel's Gilead Sciences position peaked at $3.41M in Q2 2015.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on R.H. Dinel Investment Counsel's 13F filing for Q2 2022, filed 12 Jul 2022.